×
FeedBack
Category
Data
Software
Assing to Group
Type
Add Missing Data
Correct Invalid Data
Website Bug
Add Feature
Suggest Enhancement
Info Request
Others
Group
Select Group
Drug
Trade Name
Patient Education
Toxicology
Manufacturer
Software
Quality
Severity
Urgent
High
Normal
Title
Receive Notification E-mails
Issue Details
Contact Us
Contact Us
|
Feedback
MOBILE VIEW
|
English
Chinese
<style>#search-block .headerSearchBox{border-bottom-left-radius:3px !important;border-top-left-radius:3px !important;}.show-title-for-nojs{display:none;}</style> <div id="search-title" class="show-title-for-nojs"> <label for="headerSearchKeyword">Drug. / Keyword</label> </div>
All
All
Drugs
Trand Name
Toxicologies
Patient Education
Over 200,000 approved drugs and health products.
Drugs
Drugs In USA
Drugs In Jordan
Drug Classes
Advanced Search
Drug look alike sound alike
Drug Interactions
Toxicologies
Toxicologies Classes
Toxicologies Search
Patient Education
Condition Titles
Drug Titles
Lab Titles
Manufacturers
All Manufacturers
Blogs
News
Trade Name:
SandoSTATIN Lar
Active Ingredient:
OCTREOTIDE
Manufacturer:
Novartis
Strength:
20 MG/Vial Suspension
Country:
Canada
AAPCC Code:
077823 - Other Hormone Antagonists
Address:
P.O. Box 385
Dorval, QC H9R 4P5
Canada
Availability:
Canada
Contact:
Business Hours: (514) 631-1867 (Fax)
Business Hours: (514) 631-6775 (Phone)
Form:
Injection Suspension
Manufacturer:
Novartis (Canada)
Registry Number:
DIN 02239324
Regulatory-Status:
RX